Fmr LLC X Biotech Inc. Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in X Biotech Inc. stock. As of the latest transaction made, Fmr LLC holds 21,572 shares of XBIT stock, worth $161,790. This represents 0.0% of its overall portfolio holdings.

Number of Shares

21,572

Previous 19,966 8.04%

Holding current value

$161,790

Previous $162,000 32.1%

% of portfolio

0.0%

Previous 0.0%

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$4.54 - $9.89 $7,291 - $15,883	1,606 Added 8.04%	21,572 $110,000
Q1 2024 May 13, 2024	SELL	$4.03 - $8.13 $298 - $601	-74 Reduced 0.37%	19,966 $162,000
Q2 2023 Aug 11, 2023	SELL	$3.06 - $6.38 $1,224 - $2,552	-400 Reduced 1.96%	20,040 $119,000
Q1 2023 May 11, 2023	BUY	$3.22 - $4.72 $515 - $755	160 Added 0.79%	20,440 $70,000
Q3 2022 Nov 10, 2022	SELL	$3.58 - $5.88 $3,640 - $5,979	-1,017 Reduced 4.78%	20,280 $73,000
Q2 2022 Aug 12, 2022	BUY	$5.13 - $9.2 $3,960 - $7,102	772 Added 3.76%	21,297 $120,000
Q1 2022 May 13, 2022	BUY	$8.64 - $11.71 $177,336 - $240,347	20,525 New	20,525 $177,000

Others Institutions Holding XBIT

# of Institutions

Shares Held

4.67M

Call Options Held

5.8K

Put Options Held

4.6K

View Full List

About XBiotech Inc.

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $228M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

More about XBIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account